Lixte Stock Volatility

LIXT -  USA Stock  

USD 2.72  0.07  2.51%

We consider Lixte Biotech very risky. Lixte Biotech Hlds has Sharpe Ratio of 0.0262, which conveys that the firm had 0.0262% of return per unit of risk over the last 3 months. Our standpoint towards estimating the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for Lixte Biotech, which you can use to evaluate the future volatility of the firm. Please verify Lixte Biotech Hlds Mean Deviation of 3.54, risk adjusted performance of 0.0439, and Downside Deviation of 4.4 to check out if the risk estimate we provide is consistent with the expected return of 0.12%.

Search Volatility 

 
Refresh
Lixte Biotech Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Lixte daily returns, and it is calculated using variance and standard deviation. We also use Lixte's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Lixte Biotech volatility.

30 Days Market Risk

Very risky

Chance of Distress

Significantly High

30 Days Economic Sensitivity

Slowly supersedes the market

Lixte Biotech Market Sensitivity And Downside Risk

Lixte Biotech's beta coefficient measures the volatility of Lixte stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Lixte stock's returns against your selected market. In other words, Lixte Biotech's beta of 0.34 provides an investor with an approximation of how much risk Lixte Biotech stock can potentially add to one of your existing portfolios.
Let's try to break down what Lixte's beta means in this case. As returns on the market increase, Lixte Biotech returns are expected to increase less than the market. However, during the bear market, the loss on holding Lixte Biotech will be expected to be smaller as well.
3 Months Beta |Analyze Lixte Biotech Hlds Demand Trend
Check current 90 days Lixte Biotech correlation with market (DOW)

Lixte Beta

    
  0.34  
Lixte standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  4.51  
It is essential to understand the difference between upside risk (as represented by Lixte Biotech's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Lixte Biotech stock's daily returns or price. Since the actual investment returns on holding a position in Lixte Biotech stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Lixte Biotech.

Lixte Biotech Hlds Stock Volatility Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Lixte Biotech Hlds Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input. View also all equity analysis or get more info about average price price transform indicator.

Lixte Biotech Projected Return Density Against Market

Given the investment horizon of 90 days Lixte Biotech has a beta of 0.3355 . This indicates as returns on the market go up, Lixte Biotech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Lixte Biotech Hlds will be expected to be much smaller as well.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Lixte Biotech or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Lixte Biotech stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Lixte stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The company has an alpha of 0.2061, implying that it can generate a 0.21 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Predicted Return Density 
      Returns 

Lixte Biotech Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Lixte Biotech or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Lixte Biotech stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Lixte stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Given the investment horizon of 90 days the coefficient of variation of Lixte Biotech is 3821.9. The daily returns are distributed with a variance of 20.37 and standard deviation of 4.51. The mean deviation of Lixte Biotech Hlds is currently at 3.44. For similar time horizon, the selected benchmark (DOW) has volatility of 0.73
α
Alpha over DOW
0.21
β
Beta against DOW0.34
σ
Overall volatility
4.51
Ir
Information ratio 0.0388

Lixte Biotech Stock Return Volatility

Lixte Biotech historical daily return volatility represents how much Lixte Biotech stock's price daily returns swing around its mean daily price change - it is a statistical measure of its dispersion of returns. The firm inherits 4.5133% risk (volatility on return distribution) over the 90 days horizon. By contrast, DOW inherits 0.7424% risk (volatility on return distribution) over the 90 days horizon.
 Performance (%) 
      Timeline 

About Lixte Biotech Volatility

Volatility is a rate at which the price of Lixte Biotech or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Lixte Biotech may increase or decrease. In other words, similar to Lixte's beta indicator, it measures the risk of Lixte Biotech and helps estimate the fluctuations that may happen in a short period of time. So if prices of Lixte Biotech fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company was incorporated in 2005 and is based in East Setauket, New York. Lixte Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.

Lixte Biotech Investment Opportunity

Lixte Biotech Hlds has a volatility of 4.51 and is 6.09 times more volatile than DOW. 38  of all equities and portfolios are less risky than Lixte Biotech. Compared to the overall equity markets, volatility of historical daily returns of Lixte Biotech Hlds is lower than 38 () of all global equities and portfolios over the last 90 days. Use Lixte Biotech Hlds to protect your portfolios against small market fluctuations. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Lixte Biotech to be traded at $2.61 in 90 days. . Let's try to break down what Lixte's beta means in this case. As returns on the market increase, Lixte Biotech returns are expected to increase less than the market. However, during the bear market, the loss on holding Lixte Biotech will be expected to be smaller as well.

Significant diversification

The correlation between Lixte Biotech Hlds and DJI is Significant diversification for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lixte Biotech Hlds and DJI in the same portfolio assuming nothing else is changed.

Lixte Biotech Additional Risk Indicators

The analysis of Lixte Biotech's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Lixte Biotech's investment and either accepting that risk or mitigating it. Along with some common measures of Lixte Biotech stock risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Risk Adjusted Performance0.0439
Market Risk Adjusted Performance0.6588
Mean Deviation3.54
Semi Deviation4.18
Downside Deviation4.4
Coefficient Of Variation2072.22
Standard Deviation4.72
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Lixte Biotech Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
Sentinelone Inc vs. Lixte Biotech
Visa vs. Lixte Biotech
Vmware vs. Lixte Biotech
Virtus Infracap vs. Lixte Biotech
Facebook vs. Lixte Biotech
Salesforce vs. Lixte Biotech
Walker Dunlop vs. Lixte Biotech
Otp Bank vs. Lixte Biotech
Ford vs. Lixte Biotech
Microsoft Corp vs. Lixte Biotech
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Lixte Biotech as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Lixte Biotech's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Lixte Biotech's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Lixte Biotech Hlds.
Additionally, see Stocks Correlation. Note that the Lixte Biotech Hlds information on this page should be used as a complementary analysis to other Lixte Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Lixte Stock analysis

When running Lixte Biotech Hlds price analysis, check to measure Lixte Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotech is operating at the current time. Most of Lixte Biotech's value examination focuses on studying past and present price action to predict the probability of Lixte Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lixte Biotech's price. Additionally, you may evaluate how the addition of Lixte Biotech to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
The market value of Lixte Biotech Hlds is measured differently than its book value, which is the value of Lixte that is recorded on the company's balance sheet. Investors also form their own opinion of Lixte Biotech's value that differs from its market value or its book value, called intrinsic value, which is Lixte Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lixte Biotech's market value can be influenced by many factors that don't directly affect Lixte Biotech Hlds underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lixte Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Lixte Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lixte Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.